1570P - Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)
| Autor: | Heudobler, D. 1, Schulz, C. 2, Fischer, J.R. 3, Staib, P. 4, Wehler, T. 5, Südhoff, T. 6, Schichtl, T. 7, Wilke, J. 8, Hahn, J. 1, Lüke, F. 1, Vogelhuber, M. 1, Klobuch, S. 1, Pukrop, T. 1, Herr, W. 1, Held, S. 9, Beckers, K. 10, Bouche, G. 10, Reichle, A. 1 |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v646-v647 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|